A compound of formula (I), pharmaceutical composition, method of obtaining and using said compound to prepare a medicament for the treatment and/or prophylaxis of cancer (Machine-translation by Google Translate, not legally binding)
A compound of formula (I) for preparing a medicament for the treatment and/or prophylaxis of cancer: leukemia, lymphoma, myeloma, carcinoma, melanoma and sarcoma. The compound of formula (I) can be (e) -n - ((5- (1 h -indol-2-yl) -3-methoxy-1H-pyrrol-2-yl) methylene)) dodecan-1-amine hydrochloride, (e) -n - ((5- (1H-indol-2-yl) -3-methoxy-1H-pyrrol-2-yl) methylene)) - 1,2,3,4-tetrahydronaphthalen-1- amine hydrochloride or ((e) -n - ((5- (1H-indol-2-yl) -3-methoxy-1H-pyrrol-2-yl) methylene)) - 4-tert-butylaniline hydrochloride. (Machine-translation by Google Translate, not legally binding)Un compuesto de fórmula (I) para preparar un medicamento destinado al tratamiento y/o profilaxis del cáncer: leucemia, linfoma, mieloma, carcinoma, melanoma y sarcoma. El compuesto de fórmula (I) puede ser (E)-N-((5-(1 H-indol-2-il)-3-metoxi-1H- pirrol-2-il)metileno))dodecan-1-amina hidrocloruro, (E)-N-((5-(1H-indol-2-il)-3-metoxi-1H-pirrol-2-il)metileno))-1,2,3,4-tetrahidronaftalen-1-amina hidrocloruro o ((E)-N-((5-(1H-indol-2-il)-3-metoxi-1H-pirrol-2-il)metileno))-4-tert-butilanilina hidrocloruro.
